Search results
Three Times Your Free Medicare Colonoscopy Could Cost You
Forbes· 4 days agoThe Affordable Care Act mandated no out-of-pocket costs for a colonoscopy. So if this test is...
Letter: We need alternatives to opioids
Bangor Daily News· 2 days agoAs a retired millworker, I have witnessed the devastating impact of the opioid crisis on mill towns throughout Maine and communities around the entire...
Older Americans worry they can’t afford their own health care | CNN
CNN.com· 4 days agoWhat weighs most heavily on older adults’ minds when it comes to health care? “It’s on our minds a...
Aging Matters: Ms. Senior Forsyth County pageant taking applications
Winston-Salem Journal· 6 days agoThe Ms. Senior Forsyth County pageant is looking for women aged 60 and older to take part in the...
Gateway - Quartz
Quartz· 4 days agoNovo Nordisk, the maker of the mega-popular diabetes and weight loss medications Ozempic and Wegovy, is set to report its first quarter earnings on May 2. The Danish pharma giant is one-half ...
Cost may not keep many people from filling opioid addiction treatment prescriptions
Medical Xpress· 3 days agoWhen people get a prescription for the opioid addiction medication called buprenorphine, they almost...
States struggle to help patients navigate insurance hurdle known as ‘step therapy’
Missouri Independent via Yahoo News· 5 days agoCassidy Yermal, 32, began experiencing debilitating migraines when she was 17 years old. As a...
Gateway - Quartz
Quartz· 4 days agoCenters for Medicare and Medicaid Services (CMS) announced on Thursday. “CMS has issued guidance to Medicare Part D
Ask Kevin: Can I delay my Part B enrollment and still avoid penalty?
Federal Times· 4 days agoThe following is a question submitted by a Federal Times reader to columnist Kevin Moss, a senior editor at Consumers’ Checkbook and expert on federal employee health insurance plans for civil ...
Gateway - Quartz
Quartz· 4 days agoAfter dominating the market for weight loss drugs, Ozempic maker Novo Nordisk has set its sights on tackling treatments for heart disease next. Cardior, a Germany-based drug maker, develops ...